Industry Supported Symposium
APASL STC Osaka 2021 Program of Sponsored Seminars
Luncheon Seminar 1: Sponsored by Eisai Co. Ltd. / MSD K.K.
- Chair: Junji Furuse (Japan)
- Consideration of the Decision Process of Treatment in Patients with Hepatocellular Carcinoma
- Dr. Sadahisa Ogasawara (Japan)
- Clinical Outcome of Lenvatinib Therapy in Japanese Patients with Unresectable HCC
- Dr. Kaoru Tsuchiya (Japan)
Evening Seminar 1: Sponsored by Chugai Pharmaceutical Co., Ltd.
- Chair: Dr. Kiyoshi Hasegawa (Japan)
- A New Era of Cancer Immunotherapy in Hepatocellular Carcinoma
- Dr. Masatoshi Kudo (Japan)
Morning Seminar: Sponsored by Otsuka Pharmaceutical Co., Ltd.
- Chair: Dr. Hitoshi Yoshiji (Japan)
- Management of Liver Cirrhosis: Summary of JSGE & JSH Evidence-based Clinical Practice Guidelines for Liver Cirrhosis 2020
- Dr. Naoya kato (Japan)
Luncheon Seminar 2: Sponsored by AbbVie GK
- Chair: Tatehiro Kagawa (Japan)
- Clinical Outcome of Antiviral Therapy in Patients with Hepatitis C Virus Infection
- Dr. Toshifumi Tada (Japan)
- Hepatocellular Carcinoma Developing after the Eradication of Hepatitis C Virus: Surveillance, Characteristics, and Prognosis
- Dr. Hidenori Toyoda (Japan)
Evening Seminar 2: Sponsored by Gilead Sciences K.K.
- Chair: Dr. Yasuhito Tanaka (Japan)
- Novel Agents for HBV Therapy
- Dr. Man-Fung Yuen (Hong Kong, China)
Copyright APASL Single Topic Conference 2021 Osaka. All rights reserved.